IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v47y2024i1d10.1007_s40264-023-01366-5.html
   My bibliography  Save this article

Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media

Author

Listed:
  • Cristina Micale

    (University of Pennsylvania
    Thomas Jefferson University)

  • Su Golder

    (University of York)

  • Karen O’Connor

    (University of Pennsylvania)

  • Davy Weissenbacher

    (Cedars-Sinai Medical Center)

  • Robert Gross

    (University of Pennsylvania)

  • Sean Hennessy

    (University of Pennsylvania)

  • Graciela Gonzalez-Hernandez

    (Cedars-Sinai Medical Center)

Abstract

Introduction Hypertension is the leading cause of heart disease in the world, and discontinuation or nonadherence of antihypertensive medication constitutes a significant global health concern. Patients with hypertension have high rates of medication nonadherence. Studies of reasons for nonadherence using traditional surveys are limited, can be expensive, and suffer from response, white-coat, and recall biases. Mining relevant posts by patients on social media is inexpensive and less impacted by the pressures and biases of formal surveys, which may provide direct insights into factors that lead to non-compliance with antihypertensive medication. Methods This study examined medication ratings posted to WebMD, an online health forum that allows patients to post medication reviews. We used a previously developed natural language processing classifier to extract indications and reasons for changes in angiotensin receptor II blocker (ARB) and angiotensin-converting enzyme inhibitor (ACEI) treatments. After extraction, ratings were manually annotated and compared with data from the US Food and Drug administration (FDA) Adverse Events Reporting System (FAERS) public database. Results From a collection of 343,459 WebMD reviews, we automatically extracted 1867 posts mentioning changes in ACEIs or ARBs, and manually reviewed the 300 most recent posts regarding ACEI treatments and the 300 most recent posts regarding ARB treatments. After excluding posts that only mentioned a dose change or were a false-positive mention, 142 posts in the ARBs dataset and 187 posts in the ACEIs dataset remained. The majority of posts (97% ARBs, 91% ACEIs) indicated experiencing an adverse event as the reason for medication change. The most common adverse events reported mapped to the Medical Dictionary for Regulatory Activities were “musculoskeletal and connective tissue disorders” like muscle and joint pain for ARBs, and “respiratory, thoracic, and mediastinal disorders” like cough and shortness of breath for ACEIs. These categories also had the largest differences in percentage points, appearing more frequently on WebMD data than FDA data (p

Suggested Citation

  • Cristina Micale & Su Golder & Karen O’Connor & Davy Weissenbacher & Robert Gross & Sean Hennessy & Graciela Gonzalez-Hernandez, 2024. "Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media," Drug Safety, Springer, vol. 47(1), pages 81-91, January.
  • Handle: RePEc:spr:drugsa:v:47:y:2024:i:1:d:10.1007_s40264-023-01366-5
    DOI: 10.1007/s40264-023-01366-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-023-01366-5
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-023-01366-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Su Golder & Davy Weissenbacher & Karen O’Connor & Sean Hennessy & Robert Gross & Graciela Gonzalez Hernandez, 2022. "Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media," Drug Safety, Springer, vol. 45(9), pages 971-981, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      More about this item

      Statistics

      Access and download statistics

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:47:y:2024:i:1:d:10.1007_s40264-023-01366-5. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.